Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies

Emerging SARS-CoV-2 strains, B.1.1.7 and B.1.351, from the UK and South Africa, respectively, show decreased neutralization by monoclonal antibodies and convalescent or vaccinee sera raised against the original wild-type virus, and are thus of clinical concern. However, the neutralization potency of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerutti, Gabriele, Rapp, Micah, Guo, Yicheng, Bahna, Fabiana, Bimela, Jude, Reddem, Eswar R., Yu, Jian, Wang, Pengfei, Liu, Lihong, Huang, Yaoxing, Ho, David D., Kwong, Peter D., Sheng, Zizhang, Shapiro, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188728/
https://www.ncbi.nlm.nih.gov/pubmed/34111408
http://dx.doi.org/10.1016/j.str.2021.05.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188728/
https://www.ncbi.nlm.nih.gov/pubmed/34111408
http://dx.doi.org/10.1016/j.str.2021.05.014

Ejemplares similares